175 related articles for article (PubMed ID: 10900540)
1. Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets.
Palmieri GF; Michelini S; Di Martino P; Martelli S
Drug Dev Ind Pharm; 2000 Aug; 26(8):837-45. PubMed ID: 10900540
[TBL] [Abstract][Full Text] [Related]
2. Spray-drying as a method for microparticulate controlled release systems preparation: advantages and limits. I. Water-soluble drugs.
Palmieri GF; Bonacucina G; Di Martino P; Martelli S
Drug Dev Ind Pharm; 2001; 27(3):195-204. PubMed ID: 11291199
[TBL] [Abstract][Full Text] [Related]
3. Gastro-resistant microspheres containing ketoprofen.
Palmieri GF; Bonacucina G; Di Martino P; Martelli S
J Microencapsul; 2002; 19(1):111-9. PubMed ID: 11811753
[TBL] [Abstract][Full Text] [Related]
4. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
5. Emulsion/solvent evaporation as an alternative technique in pellet preparation.
Palmieri GF; Grifantini R; Di Martino P; Martelli S
Drug Dev Ind Pharm; 2000 Nov; 26(11):1151-8. PubMed ID: 11068688
[TBL] [Abstract][Full Text] [Related]
6. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
8. Development of extended release coevaporates and coprecipitates of promethazine HCl with acrylic polymers: formulation considerations.
Dahiya S; Pathak K; Sharma R
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):504-8. PubMed ID: 18379098
[TBL] [Abstract][Full Text] [Related]
9. Floating and sustained-release characteristics of effervescent tablets prepared with a mixed matrix of Eudragit L-100-55 and Eudragit E PO.
Bani-Jaber AK; Alkawareek MY; Al-Gousous JJ; Abu Helwa AY
Chem Pharm Bull (Tokyo); 2011; 59(2):155-60. PubMed ID: 21297292
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
Obeidat WM; Nokhodchi A; Alkhatib H
AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
[TBL] [Abstract][Full Text] [Related]
11. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
12. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
13. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
14. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
[TBL] [Abstract][Full Text] [Related]
15. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
16. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
17. The effects of formulation factors on the moist granulation technique for controlled-release tablets.
Railkar AM; Schwartz JB
Drug Dev Ind Pharm; 2001 Oct; 27(9):893-8. PubMed ID: 11763466
[TBL] [Abstract][Full Text] [Related]
18. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
[TBL] [Abstract][Full Text] [Related]
19. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
Grund J; Koerber M; Walther M; Bodmeier R
Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
Ma Y; Li WZ; Chen DW
Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
